KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Minority Interest (2016 - 2026)

Medtronic's Minority Interest history spans 9 years, with the latest figure at $211.0 million for Q1 2026.

  • For Q1 2026, Minority Interest changed N/A year-over-year to $211.0 million; the TTM value through Jan 2026 reached $211.0 million, changed N/A, while the annual FY2025 figure was $232.0 million, 12.62% up from the prior year.
  • Minority Interest for Q1 2026 was $211.0 million at Medtronic, up from $204.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $240.0 million in Q3 2025 and bottomed at $170.0 million in Q3 2022.
  • The 5-year median for Minority Interest is $204.0 million (2024), against an average of $198.9 million.
  • The largest annual shift saw Minority Interest increased 18.72% in 2024 before it decreased 8.11% in 2025.
  • A 5-year view of Minority Interest shows it stood at $177.0 million in 2022, then increased by 5.65% to $187.0 million in 2023, then increased by 18.72% to $222.0 million in 2024, then dropped by 8.11% to $204.0 million in 2025, then increased by 3.43% to $211.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Minority Interest are $211.0 million (Q1 2026), $204.0 million (Q4 2025), and $240.0 million (Q3 2025).